Coronavirus (COVID-19)
The scientific community has reacted to the COVID-19 pandemic with unprecedented speed and cooperation. Key insights for saving lives are coming out of rapid genome sequencing, open data sharing and transparent scientific communications.
Grounded in experience with global health threats ranging from AIDS to Zika, our researchers are an important part of the international scientific response to the pandemic — tracking and modeling the virus' spread, developing diagnostic tests, designing vaccine trials, and working to prevent future outbreaks.
How Vaccines Are Developed
Our lives won’t return to normal without a COVID-19 vaccine. Fred Hutch experts are at the forefront of an unprecedented, global effort to conceive of and test safe and effective vaccines against this virus.
In a recent virtual event, Fred Hutch President and Director Dr. Tom Lynch talked with vaccine experts Drs. Larry Corey and John Mascola about what it will take to be successful in developing and distributing vaccines in record time.
Check out the video of the event and learn more about the vaccine process through an infographic.
In the Media
All Covid-19 Media CoverageFrom the earliest days of the COVID-19 pandemic, Fred Hutch scientists have been sharing their expertise through interviews and conversations with reporters and media outlets including the New York Times, The Wall Street Journal, the Seattle Times, NPR and many others. See a list of some of the significant coverage.
The Impact of Your Support
Fueled by your support, research to understand and contain the coronavirus is happening at a scale and moving at a speed that was unimaginable just a few months ago.
Resources & Highlights
Here are news, resources and information on the COVID-19 pandemic based our science and expertise:
Understanding Nextstrain
The scientists behind Nextstrain.org track small changes in the virus’s genetic code as it spreads from person to person. Learn how these researchers find, interpret and visualize those genetic clues.
Saving Seattle
How the city’s corporate giants banded together to flatten the curve when Seattle became the first U.S. epicenter of the coronavirus outbreak.
At much greater risk
The first large study of nearly 1,000 cancer patients who contracted COVID-19 underscored how deadly the new coronavirus can be for patients with active cancer.
‘Back to campus’
Like every other organization, Fred Hutch has no playbook for how to get employees back on-site amid a pandemic. Instead, it is tapping its scientific expertise to move forward.
Enrolling Participants: COVID-19 Clinical Trials
CovidWatch
This Fred Hutch research project is enrolling volunteers who are at high risk of being exposed to the novel coronavirus including health care workers, employees of long-term care facilities and hospitals, first responders, grocery store employees and bus drivers.
COVID-19 and Cancer Consortium
More than 30 U.S. cancer centers and organizations, including Fred Hutch and its clinical care partner Seattle Cancer Care Alliance, have come together to collect and disseminate data to better understand the scope and severity of COVID-19 in patients with cancer.
Seattle COVID Cohort
The Seattle Vaccine Trials Unit, part of Fred Hutchinson Cancer Research Center, is looking for people who are at risk for COVID or have tested positive for COVID-19 to take part in a research study. Individuals are needed to help us learn more about how the virus affects the immune system.
Hutch Researchers Connected to COVID-19
Fred Hutch researchers are committed to ending the COVID-19 pandemic — from vaccines to developing COVID-19 diagnostic and serology tests to modeling the spread of the virus.
Researchers are working together to stop this pandemic and prevent the next one —
people like Dr. Elizabeth Halloran, a global leader in using statistics and dynamic models to understand infectious disease outbreaks and to evaluate vaccines and vaccination strategies.
Support COVID-19 Research
Every dollar helps our scientists reduce the threat of the novel coronavirus.